Seong-kyu K. Kim
Daegu, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications
Risk of cardiovascular disease associated with use of tumor necrosis factor inhibitors in ankylosing spondylitis.
Journal: Journal of rheumatic diseases
Published: May 13, 2025
Rheumatoid factor and anti-cyclic citrullinated peptide antibody levels decline in rheumatoid arthritis patients treated with Janus kinase inhibitors or biological disease-modifying anti-rheumatic drugs.
Journal: Journal of rheumatic diseases
Published: March 21, 2025
Clinical Significance of Hematological Indices as Disease Activity Markers in Patients With Ankylosing Spondylitis Following Treatment With Tumor Necrosis Factor Inhibitors.
Journal: International journal of rheumatic diseases
Published: September 25, 2024
Anti-Inflammatory Effect of Atorvastatin and Rosuvastatin on Monosodium Urate-Induced Inflammation through IL-37/Smad3-Complex Activation in an In Vitro Study Using THP-1 Macrophages.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 16, 2024
Corrigendum: Korean treatment recommendations for patients with axial spondyloarthritis.
Journal: Journal of rheumatic diseases
Published: January 02, 2024
Korean treatment recommendations for patients with axial spondyloarthritis.
Journal: The Korean journal of internal medicine
Published: November 10, 2023
Risk of cardiovascular disease associated with long-term use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis.
Journal: Rheumatology (Oxford, England)
Published: September 07, 2023
The comparable efficacy of denosumab on bone mineral density in rheumatoid arthritis patients with postmenopausal osteoporosis: A retrospective case-control study.
Journal: Medicine
Published: June 30, 2023
Korean treatment recommendations for patients with axial spondyloarthritis.
Journal: Journal of rheumatic diseases
Published: May 03, 2023
Korean treatment recommendations for patients with axial spondyloarthritis.
Journal: The Korean journal of internal medicine
Published: April 27, 2023
HMG-CoA Reductase Inhibitors Suppress Monosodium Urate-Induced NLRP3 Inflammasome Activation through Peroxisome Proliferator-Activated Receptor-γ Activation in THP-1 Cells.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 03, 2023
Last Updated: 09/26/2026